Acid-base map and compensatory mechanisms

Last updated: August 08, 2023

Acid-base map and compensatory mechanisms

IM EOR

IM EOR

Angina pectoris
Premature atrial contraction
Premature ventricular contraction
Supraventricular arrhythmias: Pathology review
Ventricular tachycardia
Ventricular fibrillation
Atrial flutter
Atrial fibrillation
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Long QT syndrome and Torsade de pointes
Stable angina
Unstable angina
Prinzmetal angina
Class I antiarrhythmics: Sodium channel blockers
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Heart failure
Diabetes mellitus
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Insulins
Diabetes insipidus
Hypercalcemia
Hypocalcemia
Hypernatremia
Hyponatremia
Hyperparathyroidism
Hypoparathyroidism
Hypercholesterolemia: Clinical
Lipid-lowering medications: Statins
Coronary artery disease: Clinical
Endocarditis
Class II antiarrhythmics: Beta blockers
Peptic ulcer
Acute pancreatitis
Chronic pancreatitis
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastritis
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
ECG cardiac infarction and ischemia
Abnormal heart sounds
Pulmonary valve disease
Tricuspid valve disease
cGMP mediated smooth muscle vasodilators
Sarcoidosis
Mycobacterium tuberculosis (Tuberculosis)
Pneumonia
Myocardial infarction
Adrenergic antagonists: Beta blockers
Hyperthyroidism
Hypothyroidism
Thyroid storm
Hypertension: Clinical
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Asthma
Emphysema
Pericarditis and pericardial effusion
Cardiac tamponade
Antiplatelet medications
Primary adrenal insufficiency
Pheochromocytoma
Cushing syndrome
Ischemic stroke
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Bundle branch block
Migraine
Tension headache
Cluster headache
Syncope: Clinical
Transient ischemic attack
Non-steroidal anti-inflammatory drugs
Fibromyalgia
Gout
Systemic lupus erythematosus
Iron deficiency anemia
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Pulmonary hypertension
Pneumothorax
Lung cancer
Pulmonary embolism
Pseudomonas aeruginosa
Clostridium botulinum (Botulism)
Vitamin B12 deficiency
Influenza virus
Sickle cell disease (NORD)
Treponema pallidum (Syphilis)
Clostridium tetani (Tetanus)
Borrelia burgdorferi (Lyme disease)
Protein C deficiency
Folate (Vitamin B9) deficiency
Factor V Leiden
Protein S deficiency
Antithrombin III deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Paget disease of bone
Antiphospholipid syndrome
Rheumatoid arthritis
Ulcerative colitis
Candida
Cryptococcus neoformans
Positive and negative predictive value
Cirrhosis
Thyroid cancer
Shock
Neisseria gonorrhoeae
Pituitary adenoma
Seizures and epilepsy
Bordetella pertussis (Whooping cough)
Prostatitis
Meningitis
Vibrio cholerae (Cholera)
Testicular torsion
Epididymitis
Polycystic kidney disease
Polymyalgia rheumatica
Polymyositis
Hemorrhoid
Portal hypertension
Varicocele
Varicella zoster virus
Irritable bowel syndrome
Cytomegalovirus
Acid reducing medications
Concussion and traumatic brain injury
Hepatocellular carcinoma
Renal artery stenosis
Rheumatic heart disease
Cor pulmonale
Gastroesophageal reflux disease (GERD)
Sjogren syndrome
Huntington disease
Scleroderma
Acute cholecystitis
Viral hepatitis
Appendicitis
Diverticulosis and diverticulitis
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Glaucoma
Ascending cholangitis
Non-urothelial bladder cancers
Hydronephrosis
Celiac disease
Benign prostatic hyperplasia
Prerenal azotemia
Renal azotemia
Postrenal azotemia
Chronic kidney disease
Poststreptococcal glomerulonephritis
Membranous nephropathy
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Acute tubular necrosis
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Alport syndrome
Parkinson disease
Encephalitis
Delirium
Dementia with Lewy bodies
Vascular dementia
Frontotemporal dementia
Alzheimer disease
Adult brain tumors
Acid-base map and compensatory mechanisms
Erectile dysfunction
Acromegaly
Esophageal web
Esophageal disorders: Clinical
Colorectal cancer
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Esophageal cancer
Gastric cancer
Esophagitis: Clinical
HIV (AIDS)
Anemia of chronic disease
Beta-thalassemia
Anemia of chronic disease
Alpha-thalassemia
Multiple myeloma
Shigella
Toxoplasma gondii (Toxoplasmosis)
Histoplasmosis
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Pneumonia: Clinical

Flashcards

Acid-base map and compensatory mechanisms

0 of 6 complete

Transcript

Watch video only

Content Reviewers

Every single moment, there are trillions of biochemical reactions going on inside our bodies. These reactions are mediated by enzymes, and for these enzymes to function properly, the pH of our body fluids needs be within a tightly regulated range.

This pH depends on the ratio of the concentration of bases, mainly HCO3−, and acids, mainly CO2, and it’s calculated by a lengthy, complicated equation, known as the Henderson-Hasselbalch equation, where pH = 6.1 + log HCO3− concentration / 0.03 partial pressure of CO2.

If we focus on the pH of our arterial blood, we can design a diagram, or acid- base map, with the concentration of HCO3− on the x axis, and the partial pressure of CO2, or PCO2, on the y axis.

Using the Henderson-Hasselbalch equation, we can plot a line called an isohydric line that starts at the origin.

The term isohydric means that along these points, they all share the same or “iso-“ concentration of hydrogenated ions or same pH - “hydric”.

For example, let’s say HCO3− concentration is 24 mEq/L and PCO2 is 40 mmHg. According to the Henderson- Hasselbalch equation, this would give us a pH of 7.4. Now, we’ d have the same pH of 7.4 if there was a HCO3− concentration of 36 mEq/L and PCO2 of 60 mmHg, or with a HCO3− concentration of 12 mEq/L and a PCO2 of 20 mmHg.

In fact, we can draw out two more isohydric lines - this time for a pH of 7.35, and another for a pH of 7.45. A normal pH is between 7.35 and 7.45, so you can see that there are a lot of combinations of HCO3− concentration and PCO2 that are between these two lines that would result in a normal pH.

In fact, because it’s so important for the body to stay between these lines, the body has designed several mechanisms to maintain homeostasis or balance.

One mechanism involves the lungs, specifically the rate and depth of breathing which controls the amount of CO2 that’s breathed out.

And another mechanism involves the kidneys, which, slowly can carefully control the amount of HCO3− that’s excreted.

Now, sometimes these regulatory processes get disturbed. Specifically, if there’s a decrease in the ratio of HCO3− concentration to PCO2, the pH drops below 7.35 and we shift to the upper left part of the acid- base map, where there’s acidosis.

On the other hand, when this ratio increases, the pH rises above 7.45 and we move to the lower right part of the acid-base, where there’s alkalosis.

Acidosis and alkalosis can be classified according to their root cause as being either respiratory or metabolic.

Respiratory pH disorders result from some problem with the respiratory system, and it results in a PCO2 value that’s too low or too high.

For example, when breathing is too shallow due to diseases such as pneumonia, CO2 can’t get eliminated efficiently and accumulates in the blood. Thus, PCO2 usually rises and the pH decreases, causing a respiratory acidosis.

On our acid- base map, this could be represented by any point within a shaded area of pH values much lower than 7.35 and PCO2 above 45 mmHg. That’s only acute, though, meaning that it goes on for a limited period of time, typically a few days.

That’s because the kidneys recognize that the pH has decreased, and try to compensate for the imbalance by retaining more HCO3−, which usually rises above 26 mEq/L. This brings the pH as close to the normal line of 7.35 as possible, but it does take a few days for the kidneys to do this, so it’s considered the chronic phase of the condition.

On the flip side, if a person is breathing faster than normal, there’s excessive CO2 loss, so PCO2 decreases and the pH rises.

On the map, this shifts us into the area of respiratory alkalosis, where pH is a lot higher than 7.45 and PCO2 has dropped below 35 mmHg.

Key Takeaways

Acid-base maps and compensatory mechanisms are great tools for managing pH levels in the body. Ideally, the body should maintain a slightly alkaline pH range of 7.35 to 7.45. However, sometimes the body's pH levels can become unbalanced, usually due to an illness, like diabetic ketoacidosis.

When this happens, the body kicks off its compensatory mechanisms to restore the normal blood pH range. One mechanism involves the lungs, which through the control of the rate and depth of breathing regulate the amount of CO2 that's breathed out; and the kidneys, which carefully control the amount of HCO3 �� that's excreted.